Areas of Interest
Abnormal lipid accumulation in liver contributes to the development of type 2 diabetes mellitus (T2DM) and various liver diseases. The aim of my work is to reveal the pathological and molecular mechanisms of nonalcoholic fatty liver disease (NAFLD). We have identified several key transcriptional factors mediates the development of this disease by regulating the expression of their downstream genes. These factors will be considered as the potential treatment targets to protect against NAFLD in the future.